Wednesday, July 13, 2016

UPDATE 3-Teva says Allergan deal to close 'any time', expects U.S. antitrust clearance

NEW YORK/TEL AVIV, July 13 (Reuters) - Teva Pharmaceutical

Industries Ltd said on Wednesday it expected its $40

billion deal to buy Allergan Plc's generics business to

close "at any time," even as...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)